Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
TriSalus Life Sciences, Inc. (TLSI) had Return on Tangible Equity of 40.42% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$11.57M |
|
$-41.27M |
|
$1.91M |
|
$9.66M |
|
$20.58M |
|
$-9.01M |
|
$-1.79M |
|
$-10.81M |
|
$-10.81M |
|
$-10.80M |
|
$-10.80M |
|
$-10.81M |
|
$-10.80M |
|
$-9.01M |
|
$-8.58M |
|
43.06M |
|
43.06M |
|
$-0.96 |
|
$-0.96 |
|
| Balance Sheet Financials | |
$33.33M |
|
$1.83M |
|
$3.13M |
|
$36.46M |
|
$10.91M |
|
$32.76M |
|
$52.28M |
|
$63.19M |
|
$-26.73M |
|
$-26.73M |
|
$-26.73M |
|
49.89M |
|
| Cash Flow Statement Financials | |
$-15.53M |
|
$-0.80M |
|
$30.49M |
|
$8.88M |
|
$23.04M |
|
$14.16M |
|
$6.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.05 |
|
-- |
|
-- |
|
5.43 |
|
-1.23 |
|
83.52% |
|
-77.94% |
|
-77.94% |
|
-- |
|
-93.43% |
|
-356.86% |
|
$-16.32M |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
0.58 |
|
2.31 |
|
38.91 |
|
40.42% |
|
|
Return on Tangible Equity |
40.42% |
-29.62% |
|
-178.85% |
|
$-0.54 |
|
$-0.38 |
|
$-0.36 |
|